FENNELL GEORGE 4

4 · IDEXX LABORATORIES INC /DE · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 18, 2026

IDEXX (IDXX) EVP George Fennell Exercises Equity; 199 Shares Withheld

What Happened

George Fennell, Executive Vice President of IDEXX Laboratories (IDXX), converted vested derivative awards into shares on Feb 14, 2026 and had 199 shares withheld to cover tax liabilities (withholding value reported as $125,241 at $629.35/share). The conversion entries show acquisitions of 55, 56, 139 and 204 shares (total 454 shares), with 199 of those shares surrendered for taxes, resulting in a net issuance to him of roughly 255 shares.
On Feb 12, 2026 Fennell was granted additional derivative awards totaling 4,356 units (3,384; 162; and 810) that are reported as awards/grants (derivative securities) and vest according to staggered schedules in the footnotes.

Key Details

Transaction dates: Grants on 2026-02-12; conversions/withholding on 2026-02-14; Form 4 filed 2026-02-17.
Withholding price/value: $629.35 per share (closing price on Nasdaq on Feb 13, 2026 per footnote), 199 shares withheld = $125,241.
Grants: 3,384; 162; and 810 derivative units awarded on Feb 12, 2026 (total 4,356). Footnotes indicate some awards are stock options (vesting in installments beginning 2/14/2027 and one installment on 2/14/2030) and others are restricted stock units (RSUs) with various annual vesting start dates (2023–2026).
Shares owned after transaction: not specified in the provided filing details.
Transaction codes: A = Award/Grant, M = Exercise/conversion of derivative, F = Payment of exercise price or tax liability (share withholding). The 199-share disposal was tax withholding, not an open-market sale.
Filing timeliness: Form 4 filed Feb 17, 2026 covering events on Feb 12–14; no late-filing indication in the supplied data.

Context

This activity appears to be a routine conversion/settlement of vested equity and tax-withholding rather than an open-market sale—withholding shares to satisfy tax obligations is common after vesting or option exercises.
The Feb 12 grants are future-looking awards that vest over multiple years per the footnotes; they do not represent an immediate open-market purchase or sale.
For retail investors, purchases are often more informative than routine vesting/withholding. These entries mainly reflect compensation and tax settlement, not an expressed market view by the insider.

Form 4

Period: 2026-02-12

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2026-02-14+55→ 9,878 total
Exercise/Conversion
Common Stock
2026-02-14+56→ 9,934 total
Exercise/Conversion
Common Stock
2026-02-14+139→ 10,073 total
Exercise/Conversion
Common Stock
2026-02-14+204→ 10,277 total
Tax Payment
Common Stock
[F1]
2026-02-14$629.35/sh−199$125,241→ 10,078 total
Award
Non-Qualified Stock Option (right-to-buy)
[F2]
2026-02-12+3,384→ 3,384 total
Exercise: $617.20Exp: 2036-02-11→ Common Stock (3,384 underlying)
Award
Incentive Stock Option (right-to-buy)
[F3]
2026-02-12+162→ 162 total
Exercise: $617.20Exp: 2036-02-11→ Common Stock (162 underlying)
Award
Restricted Stock Unit
[F4]
2026-02-12+810→ 810 total
→ Common Stock (810 underlying)
Exercise/Conversion
Restricted Stock Unit
[F5]
2026-02-14−55→ 0 total
→ Common Stock (55 underlying)
Exercise/Conversion
Restricted Stock Unit
[F6]
2026-02-14−56→ 56 total
→ Common Stock (56 underlying)
Exercise/Conversion
Restricted Stock Unit
[F7]
2026-02-14−139→ 278 total
→ Common Stock (139 underlying)
Exercise/Conversion
Restricted Stock Unit
[F8]
2026-02-14−204→ 612 total
→ Common Stock (204 underlying)

Footnotes (8)

[F1]Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
[F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
[F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
[F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027.
[F5]Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023.
[F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024.
[F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
[F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.

Signature

/s/ Lily J. Lu, Attorney-in-Fact for George Fennell|2026-02-17

1 file